Identifying the best diagnostic test for Ovarian cancer in premenopausal women with non-specific symptoms, results from the ROCkeTS prospective, multicentre, cohort study.

2025-10-18 oncology Title + abstract only

Show abstract

ObjectiveDiagnosing ovarian cancer in premenopausal women is challenging due to the rarity of cancer and the ubiquity of symptoms, ovarian cysts on ultrasound, and raised serum CA125 tumour marker levels. We investigated the accuracy of risk prediction models and scores for diagnosing ovarian cancer in premenopausal women presenting to secondary care with symptoms and abnormal tests. MethodsA cohort of premenopausal women presenting with non-specific symptoms, and raised CA125 or abnormal imagi...

Identifying the best diagnostic test for Ovarian cancer in premenopausal women with non-specific symptoms, results from the ROCkeTS prospective, multicentre, cohort study.

Predicted journal destinations